Details for Patent: 10,849,891
✉ Email this page to a colleague
Which drugs does patent 10,849,891 protect, and when does it expire?
Patent 10,849,891 protects NUPLAZID and is included in one NDA.
This patent has two patent family members in two countries.
Summary for Patent: 10,849,891
Title: | Formulations of pimavanserin |
Abstract: | Provided herein are capsules containing pimavanserin, processes for manufacturing said capsule, and pharmaceutical compositions containing pimavanserin. |
Inventor(s): | Tejwani; Ravi (Monmouth Junction, NJ), Abele; Stephen Edward (White Plains, NY), Vizzotti; Emanuel Joseph (Millburn, NJ) |
Assignee: | ACADIA Pharmaceuticals Inc. (San Diego, CA) |
Application Number: | 16/836,086 |
Patent Claim Types: see list of patent claims | Use; Composition; Delivery; Dosage form; |
Drugs Protected by US Patent 10,849,891
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acadia Pharms Inc | NUPLAZID | pimavanserin tartrate | CAPSULE;ORAL | 210793-001 | Jun 28, 2018 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | TREATMENT OF HALLUCINATIONS AND DELUSIONS ASSOCIATED WITH PARKINSON'S DISEASE PSYCHOSIS | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 10,849,891
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Sweden | 1730232 | Sep 1, 2017 |
International Family Members for US Patent 10,849,891
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 3675827 | ⤷ Try a Trial | |||
World Intellectual Property Organization (WIPO) | 2019046167 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |